The Blood and Marrow Transplant Program at Northside Hospital is a collaboration between The Blood and Marrow Transplant Group of Georgia (BMTGA) and Northside Hospital.
Please e-mail your resume or send any questions to the following e-mail address: firstname.lastname@example.org
Exceeding Survival Outcome Rates in Allogeneic and Unrelated Donor Transplants
For the seventh consecutive year (2009-15) NSH-BMT, achieved survival outcomes that significantly exceeded the expected range as reported in the 2015 Center for International Blood and Marrow Transplant Research (CIBMTR) and the National Marrow Donor (NMDP) data release. There were 173 adult and pediatric transplant centers included in the analysis. *1, 2
1 Reported outcome data from bethematch.org. This survival information includes only patients who received their first allogeneic transplant between January 1, 2011 and December 31, 2013 using unrelated or related donors, and who had reported follow-up. 2 Final 2015 Transplant Center Specific Survival Report, December 16, 2015
Please go to Survival for additional NSH-BMT survival outcome data information.
Margaret Marcinkowski: Eighteen years with the NSH BMT/Leukemia Program: A life of hope and wellness
Margaret and her family in 1998 and in 2015
I had been feeling unwell for a few weeks. I had multiple issues, but it had come on gradually, so I wasn’t clear how sick I was. I was diagnosed with Acute Meylogenous Leukemia in June of 1998. I remember going to the hospital the night before my leukemia diagnosis. I was 36 years old, married and a mother of three small children ages 8, 5 and 1. The evening after I was diagnosed I was admitted to Northside Hospital. I was introduced to Dr. Gerry Connaghan and Dr. Kent Holland, who were opening their practice, The Blood and Marrow Transplant Group of Georgia at Northside Hospital. Suddenly, I felt like my luck was changing. I could be treated at Northside Hospital’s BMT/Leukemia programs and be treated by extraordinary experts in their field.
To read more of Margaret’s story, please click here.
After blood and marrow transplant, patients will need to be re-immunized with all childhood vaccinations due to their new immune systems being immature and vulnerable to diseases/infections. It is recommended that post-transplant patients begin their vaccination schedule six months after transplant unless clinically contraindicated. The Centers for Disease Control (CDC), recommends the following:
Northside Hospital’s #FaceLeukemia Gives Patients Social Media Platform to Raise Community Awareness of Complex Blood Cancer
For the September 2015 Blood Cancer Awareness Month, Northside Hospital in conjunction with the NSH-Leukemia Program, launched a month-long feature following the recent journeys of four leukemia patients through their diagnosis, treatment and recovery.
Our hope is that their stories will bring awareness to the struggles they faced battling cancer and to inspire you as much as they have inspired us to support leukemia research at Northside and Northside’s leukemia programs. Please go to Leukemia for additional NSH- Leukemia Program information.
Please view NSH-Leukemia patient journeys from illness to wellness on www.northside.com or on social media use #faceleukemia and join us on https://www.facebook.com/NorthsideHosp, https://twitter.com/NorthsideHosp and https://instagram.com/northsidehosp/.
Help create more leukemia survivors
Secure online and tax deductible giving is available to help fund research, education and other patient support services for the Leukemia Program through the Northside Hospital Foundation. Call (770) 667-4483 (GIVE) or visit give.northside.com for more information.
NSH-Leukemia Program Featured on NBC Affiliate 11 Alive News
On October 13, 2015, NSH-Leukemia Physician, Dr. Asad Bashey, spoke to 11 Alive News about Katherine Welch, a newly diagnosed NSH - Leukemia patient, who is twenty four weeks pregnant and undergoing lifesaving chemotherapy treatment for herself and unborn child.
With access to state-of-the-art diagnostic testing, comprehensive patient-centered care, and bone marrow transplant services, the NSH- Leukemia Program provides patients with the exceptional quality care needed to treat their blood-related malignancy. Please go to Leukemia for additional information.
57th Annual American Society of Hematology (ASH) Meeting: NSH-BMT/Leukemia Programs Will Present One Oral and Eight Poster Presentations
Dr. Asad Bashey will present ‘Non-Inferior survival of black versus white patients and superior outcomes for black females compared to other race/gender groups following allogeneic transplantation for hematologic malignancy: A single center multivariable analysis of 475 allografted patients’ at the 2015 annual American Society of Hematology meeting. Eight poster presentations have also been accepted.
By participating and developing state-the-art clinical research trials, the Program continues to advance the field of blood and marrow transplant and leukemia therapies, improve survival outcomes and quality of life.
Please go to Publications to review the 2015 ASH oral and poster presentations.
NSH-BMT’s CIBMTR Scientific Working Committee Leadership Recognition
After the 2014-2015 review of the CIBMTR’s Scientific Working Committees, four have been recognized as outstanding by the Advisory Committee:
These committees were identified because of their strong promotion of studies that will have a notable impact on the field, willingness to forgo studies that will not have a significant impact on the field, and focus on the effective use of CIBMTR resources. In addition, these committees have cultivated external collaborations and are notably well-organized and highly productive.
For a full list of CIBMTR Scientific Working Committee leadership recognition, please review here.
Open to Enrollment: A Multi-Center Phase I/Ib Study Evaluating the Efficacy and Safety of the Novel PI3k Delta Inhibitor TGR-1202 in Combination with Ibrutinib in Patients with Select B-Cell Malignancies
NSH-BMT Program Named as Core Clinical Transplant Center
NSH-BMT is the only transplant program in Georgia to receive the prestigious designation of Core Clinical Center from the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN). This designation is accompanied by a research grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) and the National Cancer Institute (NCI). The Program is one of 20 out of more than 120 such BMT Programs in the United States to be awarded this status.
Platelet Donation Video - Atlanta Blood Services
Hesitant about donating platelets? Our wonderful platelet hero Dave takes the guesswork out of donating! The process is very similar to donating whole blood, and with your donation you are giving the gift of life to an active blood cancer or blood disorder patient right here in Atlanta!
Call 404-459-8744 and schedule your appointment to save lives today!
The Blood and Marrow Transplant Program at Northside Hospital (NSH-BMT) provides the best of both worlds — clinical excellence and compassionate care. Committed to being the premier program in the Southeast, we provide outstanding state-of-the-art care for patients with leukemia and for those patients undergoing blood marrow and stem cell transplantation.